weight losscardiovascular diseaseWe assessed 87 overweight and obese patients with cardiovascular disease in order to explore the weight change over time, and related psychological, behavioural and environmental variables. After hospitalisation, all patients received recommendations for decreased calorie intake ...
Wegovy contains semaglutide, the same active ingredient found in Ozempic (that is approved for type 2 diabetes). Ozempic can lead to significant weight loss too, even though it's not approved for this use. In clinical studies, patients taking Wegovy (semaglutide) achieved an average weight loss...
The researchers found, however, that just two measures (knee compressive force and health-related quality of life) showed further improvement among patients with weight loss of 20% or more vs 10% or more. None of the other endpoints were significantly different, the researchers report in an art...
Other recommendations from the CPG include: If a patient responds well to a weight loss medication and loses 5 percent or more of their body weight after three months, the medication should be continued. If the medication is ineffective or the patient experiences side effects, the prescription sh...
"Since commercial weight-loss programs are for profit, they can be prohibitively expensive," Berning said. "Health care provider advice is more affordable and achievable for a wider population. Doctors can identify obesity problems earlier on and build long-term relationships with their patients."...
I can''t lose weight is a frequent refrain among obese patients. Even though a patient desires to lose extra pounds and apparently is complying with his or her physician''s recommendations, the expected weight loss often does not occur. ... KM Neil,RF Kushner - 《Postgraduate Medicine》 ...
Talking with Patients about Weight Loss: Tips for Primary Care Providers WIN Weight-control Information Network U.S. Department of Health and Human Services As a health care provider, you are in an ideal position to talk to your patients about weight control. Tis act sheet o ers tips and re...
Patients with idiopathic pulmonary fibrosis (IPF) often experience weight loss during the follow-up period. However, the prevalence and clinical impact of weight loss in these patients still need to be elucidated. This retrospective single-center study r
then we have things like a sudden loss of appetite that they are experiencing for the very first time, in most cases, of just not having a lot of what my patients have been calling “food brain,” where they're thinking about food ...